Category
CLSI C43-A2 – Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.
This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.
Product Details
- Published:
- 03/01/2010
- ISBN(s):
- 1562387200
- File Size:
- 1 file , 2 MB
- Note:
- This product is unavailable in Russia, Belarus
Related products
-
CLSI VET02
$180.00$108.00Add to cartDevelopment of Quality Control Ranges, Breakpoints, and Interpretive Categories for Antimicrobial Agents Used in Veterinary Medicine, 4th Edition, VET02Ed4E
Published by Publication Date Number of Pages CLSI 01/20/2021 88 -
CLSI X03R
$180.00$108.00Add to cartImplementing a Needlestick and Sharps Injury Prevention Program in the Clinical Laboratory, X03-R
Published by Publication Date Number of Pages CLSI 03/01/2002 35 -
CLSI VET01S
$180.00$108.00Add to cartPerformance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 5th Edition, VET01SEd5E
Published by Publication Date Number of Pages CLSI 10/01/2020 250 -
CLSI QMS17
$180.00$108.00Add to cartExternal Assessment, Audits, and Inspections of the Laboratory, 1st Edition, QMS17Ed1E
Published by Publication Date Number of Pages CLSI 08/01/2017 94